DARE

Latest SEC Filings & News for DARE

3 most recent filings and news items mentioning DARE. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/DARE/news?limit=20"

Pull DARE filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day
M&AJul 24, 2026Neutral

Dare Bioscience Announces Collaboration with Ravenna Pharma for CVaR Pathologic Trial

Dare Bioscience has entered a funding and collaboration agreement with Ravenna Pharma to evaluate a proprietary theranostic platform for the Cardiovascular Age at Risk (CVaR) tumor staging project. This partnership is significant as it introduces advanced imaging capabilities to

View filing at SEC.gov →
OtherJul 13, 2026Neutral

Dare Bioscience Files SEC Exhibit 99.1

Dare Bioscience inc. has submitted the exhibit. Market impact cannot be assessed without the full document text.

View filing at SEC.gov →
OtherJun 22, 2026Neutral

Dare Bioscience files 8-K exhibit disclosure

Dare Bioscience submitted an exhibit filing with the SEC. The filing appears to contain material information requiring public disclosure.

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.